Carcinoembryonic antigen (CEA) as an independent prognostic factor in colorectal carcinoma;Antígeno carcinoembrionario preoperatorio como factor pronóstico independiente en cáncer de colon y recto

Revista Medica de Chile

Volumn 132, Issue 6, 2004, Pages 691-700

  Bannura C, Guillermo ^a,b   Cumsille G , Miguel A ^a   Contreras P, Jaime ^a   Barrera E, Alejandro ^a   Melo L, Carlos ^a   Soto C, Daniel ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b NONE   (Chile)

Author keywords

Carcinoembryonic antigen; Colorectal neoplasms; Neoplasm staging; Tumor markers, biological

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLON TUMOR; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PROGNOSIS; RECTUM TUMOR; STATISTICAL MODEL; TUMOR LOCALIZATION;

EID: 12444300071     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. POKORNY RM, HUNT LE, GALANDIUK S. What's new with tumor markers for colorectal cancer. Dig Surg 2000; 17: 209-15.
2. ABEL ME, ROSEN L, KODNER IJ, FLESHMAN JW, HICKS T, KENNEDY HI ET AL. Task Force, American Society of Colon and Rectal Surgeons. Practice parameters for the treatment of rectal carcinoma. Supporting documentation. Dis Colon Rectum 1993; 36: 991-1006.
3. SLENTZ K, SENAGORE A, HIBBERT J, MAZIER WP, TALBOTT TM. Can preoperative and postoperative CEA predict survival after colon cancer resection? Am Surg 1994; 60: 528-32.
4. NORTHOVER J. Carcinoembryonic antigen and recurrent colorectal cancer. Gut 1986; 27: 117-22.
5. HERRERA MA, CHU TM, HOLYOKE ED. Carcinoembryonic antigen (CEA) as a prognostic and monitoring test in clinically complete resection of colorectal carcinoma. Ann Surg 1976; 183: 5-9.
6. WANEBO HJ, RAO B, PINSKY CM, HOFFMAN RG, STEARNS M, SCHWARTZ MK ET AL. Preoperative carcinoembryogenic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med 1978; 299: 448-51.
7. CHAPMAN MA, BUCKLEY D, HENSON DB, ARMITAGE NC. Preoperative carcinoembryogenic antigen in related to tumour stage and long term survival in colorectal cancer. Br J Cancer 1998; 78: 1346-9.
8. MOERTEL CG, JUDITH R, O'FALLON JR, GO VL, O'CONNELL MJ, THYNNE GS. The preoperative carcinoembryogenic antigen test in the diagnosis, staging and prognosis of colorectal cancer. Cancer 1986; 58: 603-10.
9. STAAB HJ, ANDERER FA, BRUMMENDORF T, STUMPF E, FISCHER R. Prognostic value of preoperative serum CEA level compared to clinical staging. Br J Cancer 1981; 44: 652-62.
10. CARRIQUIRY LA, PIÑEYRO A. Should carcinoembryonic antigen be used in the management of patients with colorectal cancer? Dis Colon Rectum 1999; 42: 921-9.
11. WIRATKAPUN S, KRAEMER M, SEOW-CHOEN F, HO Y-H, EU KW. High preoperative serum carcinoembryonic antigen predicts metastasic recurrence in potentially curative colonie cancer: results of a five years study. Dis Colon Rectum 2001; 44: 231-5.
12. LOUHIMO J, CARPELAN-HOLMSTRÖM M, ALFTHAN H, STENMAN U-H, JARVINEN HJ, HAGLUND C. Serum HCGB, CA 72-4 and CEA are independent prognostic factors in colorectal cancer. Int J Cancer 2002; 101: 545-8.
13. AMERICAN JOINT COMMITTEE ON CANCER (AJCC) prognostic factors consensus conference. Colorectal Working Group. Cancer 2000; 88: 1739-57.
14. TURNBULL RB, KYLE K, WATSON FR, SPRATT J. Cancer of the colon: the influence of no-touch isolation technic on survival rates. Ann Surg 1907; 166: 420-7.
15. FLEMING ID, COOPER JS, HENSON DE, HUTTER RVP, KENNEDY BJ, MURPHY GP ET AL, editors. American Joint Committee on Cancer. Cancer manual staging. 5th edition. 1997.
16. WANG JY, TANG R, CHIANG JM. Value of carcinoembryonic antigen in the management of colorectal cancer. Dis Colon Rectum 1994; 37: 272-7.
17. BIGGS CG, BALLANTYNE GH. Sensitivity versus cost effectiveness in postoperative follow up for colorectal cancer. Current Opinion in General Surgery 1994; 94-102.
18. LI DESTRI G, GRECO S, RINZIVILLO C, RACALBUTO A, CURRERI R, DI CATALDO A. Monitoring carcinoembryonic antigen in colorectal cancer: Is it still useful? Jpn J Surg 1998; 28: 1233-6.
19. GOSLIN R, O'BRIEN MJ, STEELE G, MAYER R, WILSON R, LORSON JM ET AL. Correlation of plasma CEA and CEA attaining in poorly differentiated colorectal cancer. Am J Med 1981; 71: 246-53.
20. SCOTT NA, WIEAND HS, MOERTEL CG, CHA SS, BEART RW, LIEBER MM. Colorectal cancer: Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern. Arch Surg 1987; 122: 1375-9.
21. HARRISON LE, GUILLEM JG, PATY P, COHEN AM. Preoperative carcinoembryonic antigen predicts outcomes in node negative colon cancer patients: a multivariate analysis of 572 patients. J Am Coll Surg 1997; 185: 55-9.
22. WOLMARK N, FISHER B, WIEAND HS, HENRY RS, LERNER H, LEGAULT-POISSON S ET AL. The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer-results from NSABP clinical trials. Ann Surg 1984; 199: 375-81.
23. CHU DZ, ERICKSON CA, RUSSELL MP, THOMPSON C, LANG NP, BROADWATER RJ ET AL. Prognostic significance of carcinoembryonic antigen in colorectal carcinoma. Arch Surg 1991; 126: 314-6.
24. LEWI H, BLUMGART LH, CARTER DC, GILLIS CR, HOLE D, RATCLIFFE JG ET AL. Preoperative carcinoembryonic antigen and survival in patients with colorectal cancer. Br J Surg 1984; 71: 206-8.
25. BANNURA G, CUMSILLE MA, CONTRERAS J, MELO C, DARRERA A, REINERO M ET AL. Factores pronósticos en cáncer colorrectal: análisis multivariado de 224 pacientes. Rev Méd Chile 2001; 129: 237-46.
26. BANNURA G, CUMSILLE MA, MELO C, BARRERA A, CONTRERAS J. Tratamiento quirúrgico del cáncer de colon: análisis de 120 pacientes consecutivos. Gastr Latinoam 2000; 11: 253-61.
27. REITER W, STIEBER P, REUTER C, NAGEL D, LAU-WERNER U, PAHL H, FATEH-MOGHADAM A. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma. Anticancer Res 1997; 17(4B): 2935-8.